Alaunos Therapeutics (TCRT)

• Market cap: $6.77M
• 1 day: -0.97%
• 5 days: 0.66%
• 1 month: 27.92%
• 3 months: -5.83%
• 6 months: 23.79%
• Year to date: 55.84%
• 1 year: 38.91%
• 5 years: -99.19%
• 10 years: -99.81%
• Sector: Healthcare
• Industry: Biotechnology

About: Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.

Employees: 1